Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors
Clinical trial NCT03175497 · COMPLETED
Trial details
- NCT number
- NCT03175497
- Sponsor
- Taizhou EOC Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2018-08-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.